Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Lenalidomide

2

XIX.a BAL: An excess proportion of lymphocytes

1
Last update : 05/03/2013
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
Pomalidomide
1
Thalidomide
2

Publications

Pulmonary toxicity after long-term treatment with lenalidomide in two myeloma patients.
European respiratory review : an official journal of the European Respiratory Society 2013 Mar 01;22;93-5 2013 Mar 01
Drug-induced interstitial pneumonitis due to low-dose lenalidomide.
Internal medicine (Tokyo, Japan) 2012;51;1081-5 2012
Hypersensitivity pneumonitis-like syndrome associated with the use of lenalidomide.
Chest 2007 May;131;1572-4 2007 May

Powered by

  • ^
  • Contact
  • Cookies
  • About